The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...

In a report released yesterday, Marie Thibault from BTIG reiterated a Buy rating on Masimo (MASI – Research Report), with a price target of ...

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on RxSight (RXST – Research Report), with a price target of ...

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...

O n Wednesday, BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ...

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...

For more information about the conference, email [email protected]. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative ...

January 28, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...

BTIG Life Sciences and Diagnostic Tools Analyst Massaro holds group dinner meeting with CEO Stueland and CFO Feeley on January 13 at 10:30 am. Discover outperforming stocks and invest smarter with ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...

The brokerage noted that after more than two years of cloud optimization headwinds, its recent fieldwork suggests a stronger ...